Posted by Michael Wonder on 31 Oct 2017
Thousands of patients to access Medicare subsidies for life-saving treatments
1 November 2017 - Thousands of patients will now have access to new Medicare subsidies to treat epilepsy, stroke, lymphoma, heart diseases and other life-threatening conditions.
From November 1, women with a family history of breast and ovarian cancer will also have free access to Medicare rebates for BRCA1 and BRCA 2 genetic testing. Close relatives of women found to have the mutations will also be eligible for the tests which have previously cost between $600 and $2,000.
The federal government approved all the latest recommendations from independent expert on the Medical Services Advisory Committee (MSAC), Health Minister Greg Hunt will announce on Wednesday.
